Brachydactyly Type A3 Is More Commonly Seen in Children With Short Stature But Does Not Affect Their Height Improvement by Growth Hormone Therapy

INTRODUCTION: To analyze the prevalence of brachydactyly type A3 (BDA3) in children with short stature and the effect on growth hormone (GH) therapy. METHODS: We analyzed the medical records of pediatric patients from July 2009 to July 2021. We included children with short stature defined as their h...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Huahong, Li, Yang, Li, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851664/
https://www.ncbi.nlm.nih.gov/pubmed/35185800
http://dx.doi.org/10.3389/fendo.2022.824315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851664/
https://www.ncbi.nlm.nih.gov/pubmed/35185800
http://dx.doi.org/10.3389/fendo.2022.824315

Ejemplares similares